Abstract

SummaryFunctional imaging and psychometric assessments indicate that bright light can enhance mood, attention, and cognitive performance in humans. Indirect evidence links these events to light detection by intrinsically photosensitive melanopsin-expressing retinal ganglion cells (mRGCs) [1, 2, 3, 4, 5, 6, 7, 8, 9]. However, there is currently no direct demonstration that mRGCs can have such an immediate effect on mood or behavioral state in any species. We addressed this deficit by using chemogenetics to selectively activate mRGCs, simulating the excitatory effects of bright light on this cell type in dark-housed mice. This specific manipulation evoked circadian phase resetting and pupil constriction (known consequences of mRGC activation). It also induced c-Fos (a marker of neuronal activation) in multiple nuclei in the hypothalamus (paraventricular, dorsomedial, and lateral hypothalamus), thalamus (paraventricular and centromedian thalamus), and limbic system (amygdala and nucleus accumbens). These regions influence numerous aspects of autonomic and neuroendocrine activity and are typically active during periods of wakefulness or arousal. By contrast, c-Fos was absent from the ventrolateral preoptic area (active during sleep). In standard behavioral tests (open field and elevated plus maze), mRGC activation induced behaviors commonly interpreted as anxiety like or as signs of increased alertness. Similar changes in behavior could be induced by bright light in wild-type and rodless and coneless mice, but not melanopsin knockout mice. These data demonstrate that mRGCs drive a light-dependent switch in behavioral motivation toward a more alert, risk-averse state. They also highlight the ability of this small fraction of retinal ganglion cells to realign activity in brain regions defining widespread aspects of physiology and behavior.

Highlights

  • We found significant bilateral c-Fos induction in the paraventricular hypothalamic nucleus (PVN), dorsomedial hypothalamus/dorsal hypothalamic area (DMH/DHA), and lateral hypothalamic area (LH) (Figures 2A and 2C)

  • Turning to regions outside of the hypothalamus, we explored the amygdala, as this has been reported to be light activated in humans [7] and to receive inputs from melanopsinexpressing retinal ganglion cells (mRGCs) [8]

  • CNO-treated hM3Dq-expressing mice showed no increased tendency toward helplessness when subjected to a forced swim test. This argues that the immediate effects of mRGC activation do not extend to inducing a depressive state and that the published work in this area instead relates to the effects of chronic aberrant light exposure

Read more

Summary

Introduction

Neither of these effects of CNO administration constricted the pupil or shifted the clock in control mice lacking hM3Dq expression (Figures 1E, S2B, and S2E). In mice with unilateral hM3Dq expression, CNO injection (at CT14) induced strong bilateral c-Fos expression in the suprachiasmatic nuclei (SCN; the site of the master circadian clock and major hypothalamic target of mRGCs; Figures 1F and 1G).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call